Corcept Therapeutics Inc (CORT)
22.94
+0.26
(+1.17%)
USD |
NASDAQ |
Apr 19, 16:00
22.94
0.00 (0.00%)
After-Hours: 17:30
Corcept Therapeutics Price to Book Value: 4.688 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 4.633 |
| April 17, 2024 | 4.699 |
| April 16, 2024 | 4.778 |
| April 15, 2024 | 4.729 |
| April 12, 2024 | 4.803 |
| April 11, 2024 | 4.866 |
| April 10, 2024 | 4.862 |
| April 09, 2024 | 5.201 |
| April 08, 2024 | 4.950 |
| April 05, 2024 | 5.148 |
| April 04, 2024 | 5.118 |
| April 03, 2024 | 5.240 |
| April 02, 2024 | 5.181 |
| April 01, 2024 | 5.259 |
| March 28, 2024 | 5.146 |
| March 27, 2024 | 5.173 |
| March 26, 2024 | 5.056 |
| March 25, 2024 | 5.038 |
| March 22, 2024 | 5.005 |
| March 21, 2024 | 5.056 |
| March 20, 2024 | 4.987 |
| March 19, 2024 | 4.954 |
| March 18, 2024 | 4.966 |
| March 15, 2024 | 4.746 |
| March 14, 2024 | 4.836 |
| Date | Value |
|---|---|
| March 13, 2024 | 4.944 |
| March 12, 2024 | 4.997 |
| March 11, 2024 | 4.852 |
| March 08, 2024 | 4.830 |
| March 07, 2024 | 4.776 |
| March 06, 2024 | 4.705 |
| March 05, 2024 | 4.736 |
| March 04, 2024 | 4.934 |
| March 01, 2024 | 4.915 |
| February 29, 2024 | 4.801 |
| February 28, 2024 | 4.842 |
| February 27, 2024 | 4.934 |
| February 26, 2024 | 4.725 |
| February 23, 2024 | 4.586 |
| February 22, 2024 | 4.697 |
| February 21, 2024 | 4.425 |
| February 20, 2024 | 4.613 |
| February 16, 2024 | 4.640 |
| February 15, 2024 | 4.997 |
| February 14, 2024 | 4.944 |
| February 13, 2024 | 4.709 |
| February 12, 2024 | 4.893 |
| February 09, 2024 | 4.701 |
| February 08, 2024 | 4.595 |
| February 07, 2024 | 4.548 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.078
Minimum
Apr 07 2020
8.221
Maximum
Sep 14 2023
5.085
Average
4.862
Median
Apr 26 2019
Price to Book Value Benchmarks
| Ultragenyx Pharmaceutical Inc | 12.67 |
| Alnylam Pharmaceuticals Inc | -- |
| Catalyst Pharmaceuticals Inc | 4.593 |
| United Therapeutics Corp | 1.871 |
| XOMA Corp | 3.318 |
Price to Book Value Related Metrics
| PE Ratio | 24.15 |
| PS Ratio | 5.315 |
| PEG Ratio | 3.036 |
| Price to Free Cash Flow | 20.20 |
| Price | 22.94 |
| Earnings Yield | 4.14% |
| Market Cap | 2.375B |
| PEGY Ratio | 3.036 |
| Operating PE Ratio | 23.90 |
| Normalized PE Ratio | 24.15 |